Bio

Amanda Goceljak represents public and private company clients in a range of US and cross-border transactions, primarily in the life sciences industry. Amanda advises pharmaceutical, biotechnology, medical device, diagnostics, and technology companies in the negotiation and structuring of licensing transactions, complex collaborations, joint ventures, strategic partnering, mergers, acquisitions, divestitures, and supply and distribution arrangements. Amanda also counsels private equity and venture capital clients on private financing transactions and provides general corporate representation. While attending Columbia Law School, she served as the editor in chief of the Columbia Journal of Asian Law. Prior to joining Morgan Lewis, she was an associate in the corporate practice of a prominent international law firm.